Canada Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Canada Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices


  • Products Id :- GDMEMC0255DB
  • |
  • Pages: 165
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Canada Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalData's new report, "Canada Drug Delivery Devices Market Outlook to 2023", provides key market data on the Canada Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the Canada Drug Delivery Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Drug Delivery Devices Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 Drug Delivery Devices Market, Canada 13

3.1 Drug Delivery Devices Market, Canada, Revenue ($m), 2009-2023 13

3.2 Drug Delivery Devices Market, Canada, Revenue Mix ($m), 2016 15

3.3 Drug Delivery Devices Market, Canada, Category Contribution by Revenue ($m), 2016 16

3.4 Drug Delivery Devices Market, Canada, Category Comparison by Revenue ($m), 2009-2023 17

3.5 Drug Delivery Devices Market, Canada, Revenue ($m), 2009-2016 18

3.6 Drug Delivery Devices Market, Canada, Revenue ($m), 2016-2023 20

3.7 Drug Delivery Devices Market, Canada, Volume (Units), 2009-2023 22

3.8 Drug Delivery Devices Market, Canada, Volume (Units), 2009-2016 23

3.9 Drug Delivery Devices Market, Canada, Volume (Units), 2016-2023 25

3.10 Drug Delivery Devices Market, Canada, Company Share by Revenue ($m), 2016 27

4 Central Venous Catheters Market, Canada 29

4.1 Central Venous Catheters Market, Canada, Revenue Mix ($m), 2016 29

4.2 Central Venous Catheters Market, Canada, Segment Contribution (%), 2016 30

4.3 Central Venous Catheters Market, Canada, Revenue ($m), 2009-2016 31

4.4 Central Venous Catheters Market, Canada, Revenue ($m), 2016-2023 33

4.5 Central Venous Catheters Market, Canada, Volume (Units), 2009-2016 35

4.6 Central Venous Catheters Market, Canada, Volume (Units), 2016-2023 37

4.7 Central Venous Catheters Market, Canada, Distribution Share by Revenue ($m), 2015-2016 39

4.8 Central Venous Catheters Market, Canada, Company Share by Revenue ($m), 2016 40

5 Infusion Systems Market, Canada 42

5.1 Infusion Systems Market, Canada, Revenue Mix ($m), 2016 42

5.2 Infusion Systems Market, Canada, Segment Contribution (%), 2016 43

5.3 Infusion Systems Market, Canada, Revenue ($m), 2009-2016 45

5.4 Infusion Systems Market, Canada, Revenue ($m), 2016-2023 47

5.4.1 Ambulatory Infusion Pumps Market, Canada, Revenue ($m), by Segment, 2009-2016 49

5.4.2 Syringe Pumps Market, Canada, Revenue ($m), by Segment, 2009-2016 51

5.4.3 Ambulatory Infusion Pumps Market, Canada, Revenue ($m), by Segment, 2016-2023 53

5.4.4 Syringe Pumps Market, Canada, Revenue ($m), by Segment, 2016-2023 55

5.5 Infusion Systems Market, Canada, Volume (Units), 2009-2016 57

5.6 Infusion Systems Market, Canada, Volume (Units), 2016-2023 59

5.6.1 Ambulatory Infusion Pumps Market, Canada, Volume (Units), by Segment, 2009-2016 61

5.6.2 Syringe Pumps Market, Canada, Volume (Units), by Segment, 2009-2016 63

5.6.3 Ambulatory Infusion Pumps Market, Canada, Volume (Units), by Segment, 2016-2023 65

5.6.4 Syringe Pumps Market, Canada, Volume (Units), by Segment, 2016-2023 67

5.7 Infusion Systems Market, Canada, Distribution Share by Revenue ($m), 2015-2016 69

5.8 Infusion Systems Market, Canada, Company Share by Revenue ($m), 2016 70

6 Infusion Systems Market, Canada 72

6.1 Needle Free Injections Market, Canada, Revenue ($m), 2009-2016 72

6.2 Needle Free Injections Market, Canada, Revenue ($m), 2016-2023 73

6.3 Needle Free Injections Market, Canada, Volume (Units), 2009-2016 74

6.4 Needle Free Injections Market, Canada, Volume (Units), 2016-2023 75

6.5 Needle Free Injections Market, Canada, Distribution Share by Revenue ($m), 2015-2016 76

6.6 Needle Free Injections Market, Canada, Company Share by Revenue ($m), 2016 77

7 Metered Dose Inhaler Devices Market, Canada 79

7.1 Metered Dose Inhaler Devices Market, Canada, Revenue ($m), 2009-2016 79

7.2 Metered Dose Inhaler Devices Market, Canada, Revenue ($m), 2016-2023 80

7.3 Metered Dose Inhaler Devices Market, Canada, Volume (Units), 2009-2016 81

7.4 Metered Dose Inhaler Devices Market, Canada, Volume (Units), 2016-2023 82

7.5 Metered Dose Inhaler Devices Market, Canada, Distribution Share by Revenue ($m), 2015-2016 83

7.6 Metered Dose Inhaler Devices Market, Canada, Company Share by Revenue ($m), 2016 84

8 Overview of Key Companies in Canada, Drug Delivery Devices Market 86

8.1 GlaxoSmithKline Plc 86

8.1.1 Company Overview 86

8.2 Hospira Inc 86

8.2.1 Company Overview 86

8.3 Becton Dickinson and Co 86

8.3.1 Company Overview 86

8.4 AstraZeneca Plc 86

8.4.1 Company Overview 86

8.5 Baxter International Inc 87

8.5.1 Company Overview 87

8.6 Medtronic Plc 87

8.6.1 Company Overview 87

8.7 Boehringer Ingelheim GmbH 87

8.7.1 Company Overview 87

8.8 Pfizer Inc 88

8.8.1 Company Overview 88

8.9 Merck & Co Inc 88

8.9.1 Company Overview 88

8.10 Fresenius Kabi AG 88

8.10.1 Company Overview 88

8.11 Glenmark Pharmaceuticals Ltd 89

8.11.1 Company Overview 89

9 Drug Delivery Devices Market Pipeline Products 90

10 Financial Deals Landscape 96

10.1 Acquisition 96

10.1.1 Teleflex Acquires Pyng Medical 96

10.2 Asset Transactions 98

10.2.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 98

10.3 Equity Offerings 100

10.3.1 InMed Pharma Raises USD4.3 Million in Public Offering of Units 100

10.3.2 Aequus Pharma Raises USD3.9 Million in Public Offering of Units 102

10.3.3 RepliCel Life Sciences Raises USD2 Million in Private Placement of Units 104

10.3.4 RepliCel Life Sciences Raises USD0.3 Million in Private Placement of Units 106

10.3.5 Tetra Bio-Pharma Raises USD0.8 Million in Private Placement of Units 107

10.3.6 RepliCel Life Sciences Raises USD3.3 Million in Private Placement of Units 108

10.3.7 Aequus Pharma Raises USD2 Million in Public Offering of Shares 109

10.4 Partnerships 111

10.4.1 Vetter Pharma International and Microdermics Enter into Agreement 111

10.4.2 United Therapeutics Enters into Licensing Agreement with Respira Therapeutics 112

10.4.3 CannaRoyalty Enters into Licensing Agreement with NuTrae 113

10.4.4 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 114

10.4.5 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 115

10.4.6 Hikma Pharma Enters into Licensing Agreement with Orion 117

10.4.7 Pfizer Terminates its Licensing Agreement with pSivida 118

10.4.8 Bayer Enters into Licensing Agreement with DelSiTech 119

10.4.9 BioCorRx Enters into Licensing Agreement with Therakine 120

10.5 Venture Financing 121

10.5.1 Microdermics Raises USD1 Million in Venture Financing 121

10.5.2 Microdermics Secures Venture Funding 122

11 Recent Developments 123

11.1 Corporate Communications 123

11.1.1 Jun 14, 2017: Tetra Bio-Pharma Appoints Aphria CFO, Mr. Carl Merton to the Board of Directors 123

11.1.2 Jun 01, 2017: Novelion Therapeutics Appoints John J. Orloff, M.D., to Its Board of Directors, Steps Down as EVP, Head of R&D 123

11.1.3 May 30, 2017: Tetra Bio-Pharma Strengthens its Board with the Appointment of Dr. Bill Cheliak 123

11.1.4 May 10, 2017: Tetra Bio-Pharma Strengthens Management Team 124

11.1.5 Apr 24, 2017: Tetra Bio-Pharma Accelerates Sales Strategy with the Appointment of Denis Courchesne as Vice President, Sales 124

11.1.6 Mar 31, 2017: Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors 125

11.1.7 Mar 27, 2017: Tetra Bio-Pharma Appoints Edward Miller as Vice President, Investor Relations & Corporate Communications 125

11.1.8 Feb 03, 2017: RepliCel Appoints Corporate Executive, Hugh Rogers to its Board of Directors 125

11.1.9 Jan 25, 2017: Yutaka Niihara, MD, MPH, CEO of Emmaus Appointed Executive Chairman of Generex Biotechnology 126

11.1.10 Nov 16, 2016: Nuvo Pharmaceuticals appoints new president 126

11.1.11 Nov 16, 2016: Nuvo Pharmaceuticals Appoints Jesse Ledger as President 127

11.1.12 Sep 01, 2016: Nuvo Pharmaceuticals Appoints New Chief Financial Officer 127

11.1.13 Jul 22, 2016: Aequus Appoints Ann Fehr as Chief Financial Officer 127

11.2 Financial Announcements 128

11.2.1 May 30, 2017: Aequus Provides First Quarter 2017 Financial Highlights 128

11.2.2 May 25, 2017: BioSyent Releases Q1 2017 Results 129

11.2.3 May 10, 2017: Nuvo Pharmaceuticals Announces 2017 First Quarter Results 129

11.2.4 May 09, 2017: Novelion Therapeutics Reports First Quarter 2017 Financial Results 131

11.2.5 May 01, 2017: Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights 133

11.2.6 Mar 28, 2017: Intelgenx Reports Fourth Quarter And Full-Year 2016 Financial Results 134

11.2.7 Mar 15, 2017: Novelion Therapeutics Reports Preliminary Fourth Quarter & Full Year 2016 Financial Results 135

11.2.8 Mar 15, 2017: BioSyent Releases Results for Fourth Quarter and Full Year 2016 137

11.2.9 Mar 01, 2017: Nuvo Pharmaceuticals Announces 2016 Year-End and Fourth Quarter Results 138

11.2.10 Feb 28, 2017: Pyng Medical Reports First Quarter Fiscal 2017 Results 140

11.2.11 Jan 10, 2017: Pyng Medical Reports Fiscal 2016 Financial Results 141

11.2.12 Jan 09, 2017: Novelion Therapeutics Reports Preliminary 2016 Net Product Sales and Provides 2017 Outlook 141

11.2.13 Nov 30, 2016: Aequus Provides Q3 2016 Financial Highlights With Substantial Increase in Quarter Over Quarter Revenues 142

11.2.14 Nov 23, 2016: BioSyent Releases Results for Third Quarter and First Nine Months of 2016 143

11.2.15 Nov 10, 2016: Nuvo Pharmaceuticals Announces 2016 Third Quarter Results 144

11.2.16 Nov 01, 2016: QLT Announces Third Quarter 2016 Results 146

11.2.17 Oct 03, 2016: Proteocyte Diagnostics launches Straticyte to US market at AAOMS Annual Meeting 147

11.2.18 Aug 23, 2016: Pyng Medical Reports Third Quarter Fiscal 2016 Results 149

11.2.19 Aug 12, 2016: BioSyent Releases Q2 and H1 2016 Results 149

11.2.20 Aug 10, 2016: Nuvo Pharmaceuticals Announces 2016 Second Quarter Results 150

11.2.21 Aug 09, 2016: QLT Announces Second Quarter 2016 Results 151

11.3 Legal And Regulatory 153

11.3.1 Apr 19, 2017: Novelion Therapeutics Request to Voluntarily Delist from the Toronto Stock Exchange Granted 153

11.4 Other Significant Developments 153

11.4.1 Jun 15, 2017: Trudell Medical International: Providing patient-focused solutions and reducing health system costs: our journey in the global fight against COPD 153

11.4.2 Jun 01, 2017: Aequus Pharmaceuticals and CDRD Announce Research Collaboration to Improve Cannabinoid-Based Therapeutics 155

11.4.3 Apr 27, 2017: Pendant Biosciences Announces Acceptance into JLABS Toronto 155

11.4.4 Apr 13, 2017: PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest 156

11.4.5 Jan 05, 2017: RepliCel CEO Provides 2017 Forecast 157

11.4.6 Oct 20, 2016: JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D 159

11.4.7 Aug 30, 2016: Aequus Provides Corporate Update on Commercial and Development Programs 159

11.5 Product News 161

11.5.1 Jul 12, 2017: Intelgenx Presents at BIT's 7th Annual International Symposium of Drug Delivery Systems 161

11.5.2 Nov 12, 2016: Teleflex nasal spray syringe devices recalled; may fail to deliver full dose of medication 162

11.6 Strategy And Business Planning 162

11.6.1 May 25, 2017: RepliCel CEO Provides Company Outlook 162

11.6.2 Jan 31, 2017: CrossLife Awarded NIH SBIR Grant to Point of Care Detection of Zika virus 163

11.6.3 Oct 06, 2016: Precision NanoSystems New Headquarters Designed to Enhance Product and Service Offerings to Customers Developing Novel Nanomedicines 163

12 Appendix 165

12.1 Research Methodology 166

12.1.1 Coverage 166

12.1.2 Secondary Research 166

12.1.3 Primary Research 167

12.1.4 Company Share Analysis 167

12.1.5 Distribution Share Analysis 167

12.1.6 Benchmarking 168

12.2 GlobalData Consulting 168

12.3 Contact Us 169

12.4 Disclaimer 169

1.2 List of Figures

Figure 1: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2009-2023 13

Figure 2: Drug Delivery Devices Market, Canada, Revenue Mix ($m), 2016 15

Figure 3: Drug Delivery Devices Market, Canada, Category Contribution (%), 2016 16

Figure 4: Drug Delivery Devices Market, Canada, Category Comparison by Revenue ($m), 2009-2023 17

Figure 5: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 18

Figure 6: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 20

Figure 7: Drug Delivery Devices Market, Canada, Volume (Units), 2009-2023 22

Figure 8: Drug Delivery Devices Market, Canada, Volume (Units), Historic, 2009-2016 23

Figure 9: Drug Delivery Devices Market, Canada, Volume (Units), Forecast, 2016-2023 25

Figure 10: Drug Delivery Devices Market, Canada, Company Share (%) 2016 27

Figure 11: Central Venous Catheters Market, Canada, Revenue Mix ($m), 2016 29

Figure 12: Central Venous Catheters Market, Canada, Segment Contribution (%), 2016 30

Figure 13: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 31

Figure 14: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 33

Figure 15: Central Venous Catheters Market, Canada, Volume (Units), Historic, 2009-2016 35

Figure 16: Central Venous Catheters Market, Canada, Volume (Units), Forecast, 2016-2023 37

Figure 17: Central Venous Catheters Market, Canada, Company Share (%) 2016 40

Figure 18: Infusion Systems Market, Canada, Revenue Mix ($m), 2016 42

Figure 19: Infusion Systems Market, Canada, Segment Contribution (%), 2016 43

Figure 20: Infusion Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 45

Figure 21: Infusion Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 47

Figure 22: Ambulatory Infusion Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 49

Figure 23: Syringe Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 51

Figure 24: Ambulatory Infusion Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 53

Figure 25: Syringe Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 55

Figure 26: Infusion Systems Market, Canada, Volume (Units), Historic, 2009-2016 57

Figure 27: Infusion Systems Market, Canada, Volume (Units), Forecast, 2016-2023 59

Figure 28: Ambulatory Infusion Pumps Market, Canada, Volume (Units), Historic, 2009-2016 61

Figure 29: Syringe Pumps Market, Canada, Volume (Units), Historic, 2009-2016 63

Figure 30: Ambulatory Infusion Pumps Market, Canada, Volume (Units), Forecast, 2016-2023 65

Figure 31: Syringe Pumps Market, Canada, Volume (Units), Forecast, 2016-2023 67

Figure 32: Infusion Systems Market, Canada, Company Share (%) 2016 70

Figure 33: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 72

Figure 34: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 73

Figure 35: Needle Free Injections Market, Canada, Volume (Units), Historic, 2009-2016 74

Figure 36: Needle Free Injections Market, Canada, Volume (Units), Forecast, 2016-2023 75

Figure 37: Needle Free Injections Market, Canada, Company Share (%) 2016 77

Figure 38: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 79

Figure 39: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 80

Figure 40: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Historic, 2009-2016 81

Figure 41: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Forecast, 2016-2023 82

Figure 42: Metered Dose Inhaler Devices Market, Canada, Company Share (%) 2016 84

1.1 List of Tables

Table 1: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2009-2023 14

Table 2: Drug Delivery Devices Market, Canada, Category Contribution by Revenue ($m), 2016 16

Table 3: Drug Delivery Devices Market, Canada, Category Comparison by Revenue ($m), 2009-2023 17

Table 4: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 19

Table 5: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 21

Table 6: Drug Delivery Devices Market, Canada, Volume (Units), 2009-2023 22

Table 7: Drug Delivery Devices Market, Canada, Volume (Units), Historic, 2009-2016 24

Table 8: Drug Delivery Devices Market, Canada, Volume (Units), Forecast, 2016-2023 26

Table 9: Drug Delivery Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 28

Table 10: Central Venous Catheters Market, Canada, Segment Contribution (%), 2016 30

Table 11: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 32

Table 12: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Table 13: Central Venous Catheters Market, Canada, Volume (Units), Historic, 2009-2016 36

Table 14: Central Venous Catheters Market, Canada, Volume (Units), Forecast, 2016-2023 38

Table 15: Central Venous Catheters Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39

Table 16: Central Venous Catheters Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 41

Table 17: Infusion Systems Market, Canada, Segment Contribution (%), 2016 44

Table 18: Infusion Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 46

Table 19: Infusion Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 48

Table 20: Ambulatory Infusion Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 50

Table 21: Syringe Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 52

Table 22: Ambulatory Infusion Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 54

Table 23: Syringe Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 56

Table 24: Infusion Systems Market, Canada, Volume (Units), Historic, 2009-2016 58

Table 25: Infusion Systems Market, Canada, Volume (Units), Forecast, 2016-2023 60

Table 26: Ambulatory Infusion Pumps Market, Canada, Volume (Units), Historic, 2009-2016 62

Table 27: Syringe Pumps Market, Canada, Volume (Units), Historic, 2009-2016 64

Table 28: Ambulatory Infusion Pumps Market, Canada, Volume (Units), Forecast, 2016-2023 66

Table 29: Syringe Pumps Market, Canada, Volume (Units), Forecast, 2016-2023 68

Table 30: Infusion Systems Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 69

Table 31: Infusion Systems Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 71

Table 32: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 72

Table 33: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 73

Table 34: Needle Free Injections Market, Canada, Volume (Units), Historic, 2009-2016 74

Table 35: Needle Free Injections Market, Canada, Volume (Units), Forecast, 2016-2023 75

Table 36: Needle Free Injections Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 76

Table 37: Needle Free Injections Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 78

Table 38: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 79

Table 39: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 80

Table 40: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Historic, 2009-2016 81

Table 41: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Forecast, 2016-2023 82

Table 42: Metered Dose Inhaler Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 83

Table 43: Metered Dose Inhaler Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 85

Table 44: Drug Delivery Devices Market Pipeline Products 90

Table 45: Teleflex Acquires Pyng Medical 96

Table 46: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 98

Table 47: InMed Pharma Raises USD4.3 Million in Public Offering of Units 100

Table 48: Aequus Pharma Raises USD3.9 Million in Public Offering of Units 102

Table 49: RepliCel Life Sciences Raises USD2 Million in Private Placement of Units 104

Table 50: RepliCel Life Sciences Raises USD0.3 Million in Private Placement of Units 106

Table 51: Tetra Bio-Pharma Raises USD0.8 Million in Private Placement of Units 107

Table 52: RepliCel Life Sciences Raises USD3.3 Million in Private Placement of Units 108

Table 53: Aequus Pharma Raises USD2 Million in Public Offering of Shares 109

Table 54: Vetter Pharma International and Microdermics Enter into Agreement 111

Table 55: United Therapeutics Enters into Licensing Agreement with Respira Therapeutics 112

Table 56: CannaRoyalty Enters into Licensing Agreement with NuTrae 113

Table 57: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 114

Table 58: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 115

Table 59: Hikma Pharma Enters into Licensing Agreement with Orion 117

Table 60: Pfizer Terminates its Licensing Agreement with pSivida 118

Table 61: Bayer Enters into Licensing Agreement with DelSiTech 119

Table 62: BioCorRx Enters into Licensing Agreement with Therakine 120

Table 63: Microdermics Raises USD1 Million in Venture Financing 121

Table 64: Microdermics Secures Venture Funding 122

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

GlaxoSmithKline Plc

Hospira Inc

Becton Dickinson and Co

AstraZeneca Plc

Baxter International Inc

Medtronic Plc

Boehringer Ingelheim GmbH

Pfizer Inc

Merck & Co Inc

Fresenius Kabi AG

Glenmark Pharmaceuticals Ltd

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license
Single User License
USD 5995 INR 430321
Site License
USD 11990 INR 860642
Corporate User License
USD 17985 INR 1290963

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com